HighVista Strategies »

Maze Therapeatics shares owned by HighVista Strategies

Quarter-by-quarter ownership of Maze Therapeatics (MAZE) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Maze Therapeatics

Tip: Access up to 7 years of quarterly data

All positions including Maze Therapeatics held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maze Therapeatics by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2025-12-31 $7.1M 170k 41.43

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Structure Therapeutics Sponsored Ads (GPCR)
Cogent Biosciences (COGT)
Miragen Therapeutics (VRDN)
Abivax Sa Sponsored Ads (ABVX)
Revolution Medicines (RVMD)
Praxis Precision Medicines I Com New (PRAX)
Nuvalent Inc-a (NUVL)
Cytokinetics Com New (CYTK)
Terns Pharmaceuticals (TERN)
Maze Therapeatics (MAZE)
Insmed Com Par $.01 (INSM)
Apogee Therapeutics (APGE)
Protagonist Therapeutics (PTGX)
Soleno Therapeutics (SLNO)

View all positions for HighVista Strategies

Top funds holding Maze Therapeatics

Frazier Life Sciences Management
Trv Gp Iv
Deep Track Capital
Arch Venture Corp
BlackRock
AH Capital Management
Vanguard Group
VR Adviser
Alphabet
General Catalyst Group Management
Woodline Partners
TRV GP V
Logos Global Management
Bellevue Group
Marshall Wace

View all funds holding Maze Therapeatics